Evidence map›Paper›PMID 32904659›Full record

ArticleJournal of inflammation research2020

Comprehensive Evaluation of Lipopolysaccharide-Induced Changes in Rats Based on Metabolomics.

Chunmei Geng, Yujin Guo, Changshui Wang, Changmeng Cui, Wenxiu Han, Dehua Liao, Pei Jiang

Abstract read
In one paragraph

Article in Journal of inflammation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chunmei GengDepartment of Pharmacy, Jining First People's Hospital, Jining Medical University, Jining 272000, People's Republic of China.
Yujin GuoDepartment of Pharmacy, Jining First People's Hospital, Jining Medical University, Jining 272000, People's Republic of China.
Changshui WangDepartment of Clinical Translational Medicine, Jining Life Science Center, Jining 272000, People's Republic of China.
Changmeng CuiDepartment of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining 272000, People's Republic of China.
Wenxiu HanDepartment of Pharmacy, Jining First People's Hospital, Jining Medical University, Jining 272000, People's Republic of China.
Dehua LiaoDepartment of Pharmacy, Hunan Cancer Hospital, Central South University, Changsha 410011, People's Republic of China.
Pei JiangDepartment of Pharmacy, Jining First People's Hospital, Jining Medical University, Jining 272000, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSubstantial evidence indicates that lipopolysaccharide (LPS) exposure can lead to systemic inflammatory response syndrome (SIRS) and multiple organ failure. Previous metabolomic studies have mainly focused on LPS-induced depression or hepatic and renal effects. However, no comprehensive metabolomics-based analysis of the serum, liver, kidney, hippocampus, and heart following exposure to LPS has been undertaken to date. MATERIAL AND

methodsMale Sprague-Dawley rats were randomly allocated to a control and a LPS-treated group (n=8). LPS for 2 weeks (0.5 mg/kg every other day) was given via intraperitoneal injection. Gas chromatography-mass spectrometry (GC-MS) was used for metabolite determination, while multivariate statistical analysis was performed to identify differentially expressed metabolites between the two groups.

resultsOur study revealed that 24, 13, 12, 7, and 12 metabolites were differentially expressed between the LPS treatment group and the control group in the serum, liver, kidney, hippocampus, and heart, respectively. We further identified that these metabolic changes were mainly involved with aminoacyl-tRNA biosynthesis; glutathione metabolism; glyoxylate and dicarboxylate metabolism; glycine, serine, and threonine metabolism; arginine biosynthesis; bile acid biosynthesis; and glycerolipid metabolism.

conclusionWe have systematically elucidated the metabolic changes underlying LPS-induced SIRS, thereby providing insight into the mechanisms associated with these alterations.

Indexed as

gas chromatography–mass spectrometrymetabolitesmultivariate statistical analysissystemic inflammatory response syndrome

Identifiers

PMID32904659
PMCPMC7457572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.